IGF1 and prostate carcinoma: Patients with prostate cancer had higher serum IGF‐1 (143.8 vs 118.9 ng/mL) and PSA (8.6 vs 5.6 ng/mL) levels than men without prostate cancer (all P < 0.001; Table S1).